Daily Practice

Merit-based Incentive Payment System (MIPS)

Latest in MIPS

Promoting Interoperability hardship applications for 2018 must be submitted by December 31.  Have questions? Contact us!

Learn about the QOPI Reporting Registry for data submission and see the full 2018 quality measure list!


2018 is the second year for the Quality Payment Program (QPP). Most radiation oncologists will participate in the Merit-based Incentive Payment System (MIPS) program. Based on an eligible clinician’s performance in four categories in 2018, their 2020 Medicare Part B reimbursement will be impacted. CMS expects over 98 percent of radiation oncologists to receive a positive or neutral payment adjustment. In preparation for MIPS, you need to answer the following questions:

  • Am I eligible?  
  • Do I qualify for any bonus points? 
  • How do I want to participate in 2018?  
  • How do I want to submit the data to CMS? 
  • How can ASTRO help me succeed? 
Bonus Points
Performance Categories
Data Submission
Application of Payment Adjustments
ASTRO Products for Success

Practice Size

Understanding the requirements based on your practice size is a key step in determining a plan for participation and reporting. Choose from one of the two links below to learn more about the specifics:

Solo or Small Practice My radiation oncology practice is just me or a group of 15 or less eligible clinicians.
Large Practice My practice is over 15 eligible clinicians.

If your practice is part of an academic university, community hospital or large multi-specialty group there is a strong likelihood that a third-party might be managing MIPS reporting on your behalf. Confirm with your administration what the entity is doing to satisfy the MIPS requirements. Additionally, if you are participating in RO-ILS or APEx, the entire group entity could receive credit for the Improvement Activities performance category. Learn more about how radiation oncology activities could benefit the group. 


Please check back regularly to see the latest updates. ASTRO is continually updating this site to reflect new and/or changing information from the federal government and other sources.

As always, each radiation oncology practice and its eligible clinicians are encouraged to review primary materials (statutes, regulations, agency interpretive guidance, etc.) and seek appropriate legal or other professional guidance for a comprehensive understanding of their obligations. The information on this website should not be construed as legal, coding or other professional advice, and ASTRO assumes no liability for the information contained herein.